{"count": 4, "results": [{"_id": "16890918", "pmid": 16890918, "title": "Simvastatin prolongs survival times in prion infections of the central nervous system.", "journal": "Biochem Biophys Res Commun", "authors": ["Mok SW", "Thelen KM", "Riemer C", "Bamme T", "Gültner S", "Lütjohann D", "Baier M"], "date": "2006-09-22T00:00:00Z", "doi": "10.1016/j.bbrc.2006.07.123", "meta_date_publication": "2006 Sep 22", "meta_volume": "348", "meta_issue": "2", "meta_pages": "697-702", "score": 50079.926, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ prolongs survival times in @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion infections@@@ of the central nervous system.", "citations": {"NLM": "Mok SW, Thelen KM, Riemer C, Bamme T, Gültner S, Lütjohann D, Baier M. Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun. 2006 Sep 22;348(2):697-702. PMID: 16890918", "BibTeX": "@article{16890918, title={Simvastatin prolongs survival times in prion infections of the central nervous system.}, author={Mok SW and Thelen KM and Riemer C and Bamme T and Gültner S and Lütjohann D and Baier M}, journal={Biochem Biophys Res Commun}, volume={348}, number={2}, pages={697-702}}"}}, {"_id": "18789130", "pmid": 18789130, "pmcid": "PMC2556658", "title": "Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells", "journal": "BMC Biol", "authors": ["Bate C", "Tayebi M", "Diomede L", "Salmona M", "Williams A"], "date": "2008-09-12T00:00:00Z", "doi": "10.1186/1741-7007-6-39", "meta_date_publication": "2008 Sep 12", "meta_volume": "6", "meta_issue": "", "meta_pages": "39", "score": 50071.72, "text_hl": "We report that treatment with @CHEMICAL_Docosahexaenoic_Acids @CHEMICAL_MESH:D004281 @@@docosahexaenoic acid@@@ (@CHEMICAL_Docosahexaenoic_Acids @CHEMICAL_MESH:D004281 @@@DHA@@@), @CHEMICAL_Eicosapentaenoic_Acid @CHEMICAL_MESH:D015118 @@@eicosapentaenoic acid@@@ (@CHEMICAL_Eicosapentaenoic_Acid @CHEMICAL_MESH:D015118 @@@EPA@@@) or the @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ synthesis inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced the amounts of free @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ in membrane extracts from @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion@@@-@DISEASE_Infections @DISEASE_MESH:D007239 @@@infected@@@ neuronal cells. ", "citations": {"NLM": "Bate C, Tayebi M, Diomede L, Salmona M, Williams A. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells BMC Biol. 2008 Sep 12;6():39. PMID: 18789130", "BibTeX": "@article{18789130, title={Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells}, author={Bate C and Tayebi M and Diomede L and Salmona M and Williams A}, journal={BMC Biol}, volume={6}, pages={39}}"}}, {"_id": "18541796", "pmid": 18541796, "title": "Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.", "journal": "Arch Neurol", "authors": ["Haviv Y", "Avrahami D", "Ovadia H", "Ben-Hur T", "Gabizon R", "Sharon R"], "date": "2008-06-01T00:00:00Z", "doi": "10.1001/archneur.65.6.762", "meta_date_publication": "2008 Jun", "meta_volume": "65", "meta_issue": "6", "meta_pages": "762-75", "score": 50068.93, "text_hl": "Induced neuroprotection independently from @GENE_PRNP @GENE_19122 @@@PrPSc@@@ accumulation in a @SPECIES_10090 @@@mouse@@@ model for @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion disease@@@ treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Haviv Y, Avrahami D, Ovadia H, Ben-Hur T, Gabizon R, Sharon R. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch Neurol. 2008 Jun;65(6):762-75. PMID: 18541796", "BibTeX": "@article{18541796, title={Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.}, author={Haviv Y and Avrahami D and Ovadia H and Ben-Hur T and Gabizon R and Sharon R}, journal={Arch Neurol}, volume={65}, number={6}, pages={762-75}}"}}, {"_id": "24059335", "pmid": 24059335, "title": "Hybrid molecules synergistically acting against protein aggregation diseases.", "journal": "Curr Top Med Chem", "authors": ["Korth C", "Klingenstein R", "Müller-Schiffmann A"], "date": "2013-01-01T00:00:00Z", "doi": "10.2174/15680266113136660175", "meta_date_publication": "2013", "meta_volume": "13", "meta_issue": "19", "meta_pages": "2484-90", "score": 50044.695, "text_hl": "Here, we review the pharmaceutical strategy of generating hybrid compounds, i.e. compounds consisting of several independently acting moieties with synergistic effects, on key molecular players in @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@ and @DISEASE_Creutzfeldt_Jakob_Syndrome @DISEASE_MESH:D007562 @@@CJD@@@. For @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion diseases@@@, we review hybrid compounds consisting of two different @CHEMICAL_Heterocyclic_Compounds @CHEMICAL_MESH:D006571 @@@heterocyclic compounds@@@, their synergistic effects on @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion@@@ replication in a cell culture model and their ability to prolong survival of experimentally @<m>DISEASE_Prion_Diseases</m> @DISEASE_MESH:D017096 @@@prion-infected@@@ @SPECIES_10090 @@@mice@@@ in vivo. ", "citations": {"NLM": "Korth C, Klingenstein R, Müller-Schiffmann A. Hybrid molecules synergistically acting against protein aggregation diseases. Curr Top Med Chem. 2013;13(19):2484-90. PMID: 24059335", "BibTeX": "@article{24059335, title={Hybrid molecules synergistically acting against protein aggregation diseases.}, author={Korth C and Klingenstein R and Müller-Schiffmann A}, journal={Curr Top Med Chem}, volume={13}, number={19}, pages={2484-90}}"}}]}